Karan Mehta, Founder & CEO at Bluezone Insurance, tells Qorus' Boris Plantier about his company, a specialist life insurance provider offering personalized cover to individuals living with chronic conditions.
What led to the creation of Bluezone?
I started my medical career in the NHS (British national health service), where I worked for three and a half years. In medical school, I found the experience intellectually stimulating and fulfilling, knowing I was on a path to help people live healthier, happier, and longer lives.
My decision to leave the NHS didn’t happen overnight. I had many ideas that I wanted to pursue, but implementing them within the existing system proved challenging. Moreover, my impact was limited to the patients I saw on the wards, and I wanted to create something proactive that could positively influence millions of people globally.
The alignment of incentives was what intrigued me most about the insurance industry, particularly in the areas of life and health insurance. This industry has the potential to offer proactive solutions and make a significant impact on people’s lives.
Currently, more than five million people in the UK have been diagnosed with diabetes, and some cases remain undiagnosed. Approximately 90% of these individuals have type 2 diabetes, while the remaining 10% have type 1 diabetes. This translates to about 6-8% of the UK population.
Demand for insurance among those with chronic conditions is high due to increased mortality risk and reduced life expectancy after diagnosis. However, the quality of products is lacking, with challenges in underwriting and access. These insights prompted me to create Bluezone, aiming to improve insurance access and support policyholders in leading healthier lives.
